Department of Endocrinology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, Sichuan, China.
Department of Respiratory and Critical Care Medicine, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, 278 Baoguang Street, Chengdu, 610500, Sichuan, China.
Respir Res. 2020 Nov 9;21(1):294. doi: 10.1186/s12931-020-01554-2.
The objective was to determine whether OSA patients have a low serum vitamin D level by systematic review and meta-analysis.
This study searched the following electronic bibliographic databases: Embase, Medline, Web of Science, PubMed, VIP, Wanfang, CNKI and SinoMed. All data were searched between January 2000 and August 2020. The quality of the included studies was estimated by two researchers according to the Newcastle-Ottawa Scale and Agency for Healthcare Research and Quality. All qualified studies and statistical analyses were conducted using RevMan 5.2.
Twenty-nine eligible studies compromising 6717 participants met the inclusion criteria of the meta-analysis. The results revealed that the serum 25(OH)D level was significantly lower in OSA patients than the controls. According to the severity of the disease, subgroup analysis was performed; the results demonstrated that the serum 25(OH)D level was not decreased in mild OSA patients compared with the controls, while the serum 25(OH)D level in moderate and severe OSA patients was lower than that in the controls. Furthermore, based on ethnicity, BMI, PSG type, study quality and latitude, the subjects were divided into different subgroups for meta-analysis. The results revealed that the serum 25(OH)D level in all OSA subgroups was decreased compared with that in the control group.
The present meta-analysis shows that the serum vitamin D level was different between OSA patients and healthy people. OSA patients could have a low serum vitamin D level.
本研究旨在通过系统评价和荟萃分析来确定阻塞性睡眠呼吸暂停(OSA)患者的血清维生素 D 水平是否较低。
本研究检索了以下电子文献数据库:Embase、Medline、Web of Science、PubMed、VIP、Wanfang、CNKI 和 SinoMed。所有数据均检索自 2000 年 1 月至 2020 年 8 月。两名研究人员根据纽卡斯尔-渥太华量表(Newcastle-Ottawa Scale)和美国卫生保健研究与质量署(Agency for Healthcare Research and Quality)评估纳入研究的质量。所有合格研究和统计分析均使用 RevMan 5.2 进行。
共有 29 项符合纳入标准的研究纳入荟萃分析,共包含 6717 名参与者。结果表明,OSA 患者的血清 25(OH)D 水平明显低于对照组。根据疾病严重程度进行亚组分析,结果表明,与对照组相比,轻度 OSA 患者的血清 25(OH)D 水平并未降低,而中度和重度 OSA 患者的血清 25(OH)D 水平低于对照组。此外,根据种族、BMI、PSG 类型、研究质量和纬度,将研究对象分为不同的亚组进行荟萃分析。结果表明,所有 OSA 亚组的血清 25(OH)D 水平均低于对照组。
本荟萃分析表明,OSA 患者和健康人群的血清维生素 D 水平存在差异,OSA 患者可能存在血清维生素 D 水平降低的情况。